Assessment of Safety, Immunogenicity and Efficacy of R21/Matrix-M1 Malaria Vaccine in Healthy WOCBP in Mali
Clinical trial NCT06080243 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06080243
- Sponsor
- University of Oxford
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-19
- Primary completion
- 2027-09-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.